RxDoctor Payments Data

Emily Parker

Women's Health · Grand Rapids, MINPI 1639404288

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 100 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 22.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $956 and has fallen 60.9% since, to $374 in 2025. Among women's health clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,619in general payments, 2019–2025

Across 100 payments — averaging $26.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pharmacyclics LLC, An Abbvie Company$582
  • Gilead$227
  • GSK$181
  • Takeda Pharmaceuticals U.S.A., Inc.$171
  • Johnson & Johnson$149
  • AbbVie$122
  • plus $1K from 32 others

What the payments were for

  • Food & beverage$2,619100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,619 in reported general payments places this provider in the 90th percentile of 91 women's health providers in Michigan.

See all women's health providers in Michigan

Medicare billing

Part B allowed, 2024
$28,366
Medicare patients
92
Services billed
5,233

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Exemestane41$7,375
Anastrozole179$5,511
Letrozole35$1,333
Tamoxifen Citrate20$851
Nystatin14$151
Gabapentin17$143
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen11$140

Paid to pharmacies, not to this prescriber.

Other women's health in Grand Rapids

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →